{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:53:22Z","timestamp":1772211202218,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00109-009-0572-y","type":"journal-article","created":{"date-parts":[[2010,1,8]],"date-time":"2010-01-08T09:24:33Z","timestamp":1262942673000},"page":"115-120","source":"Crossref","is-referenced-by-count":97,"title":["Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications"],"prefix":"10.1007","volume":"88","author":[{"given":"Alexander","family":"Laarman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fin","family":"Milder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos","family":"van Strijp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzan","family":"Rooijakkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,9]]},"reference":[{"key":"572_CR1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058\u20131066","journal-title":"N Engl J Med"},{"key":"572_CR2","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood.V89.8.2863","volume":"89","author":"K Hartmann","year":"1997","unstructured":"Hartmann K, Henz BM, Kr\u00fcger-Krasagakes S, K\u00f6hl J, Burger R, Guhl S, Haase I, Lippert U, Zuberbier T (1997) C3a and C5a stimulate chemotaxis of human mast cells. Blood 89:2863\u20132870","journal-title":"Blood"},{"key":"572_CR3","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1084\/jem.181.6.2119","volume":"181","author":"PJ Daffern","year":"1995","unstructured":"Daffern PJ, Pfeifer PH, Ember JA, Hugli TE (1995) C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181:2119\u20132127","journal-title":"J Exp Med"},{"key":"572_CR4","doi-asserted-by":"crossref","first-page":"16879","DOI":"10.1073\/pnas.0406678101","volume":"101","author":"EA Nordahl","year":"2004","unstructured":"Nordahl EA, Rydeng\u00e5rd V, Nyberg P, Nitsche DP, M\u00f6rgelin M, Malmsten M, Bj\u00e5rck L, Schmidtchen A (2004) Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci USA 101:16879\u201316884","journal-title":"Proc Natl Acad Sci USA"},{"key":"572_CR5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nri2231","volume":"8","author":"P Gros","year":"2008","unstructured":"Gros P, Milder F, Janssen B (2008) Complement driven by conformational changes. Nat Rev Immunol 8:48\u201358","journal-title":"Nat Rev Immunol"},{"key":"572_CR6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.it.2007.06.002","volume":"28","author":"N Borregaard","year":"2007","unstructured":"Borregaard N, S\u00f8rensen OE, Theilgaard-M\u00f6nch K (2007) Neutrophil granules: a library of innate immunity proteins. Trends Immunol 28:340\u2013345","journal-title":"Trends Immunol"},{"key":"572_CR7","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.molimm.2009.04.025","volume":"46","author":"AM Blom","year":"2009","unstructured":"Blom AM, Hallstr\u00f6m T, Riesbeck K (2009) Complement evasion strategies of pathogens\u2014acquisition of inhibitors and beyond. Mol Immunol 46:2808\u20132817","journal-title":"Mol Immunol"},{"key":"572_CR8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrmicro1824","volume":"6","author":"JD Lambris","year":"2008","unstructured":"Lambris JD, Ricklin D, Geisbrecht BV (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6:132\u2013142","journal-title":"Nat Rev Microbiol"},{"key":"572_CR9","first-page":"221","volume":"632","author":"BV Geisbrecht","year":"2008","unstructured":"Geisbrecht BV (2008) Staphylococcal complement inhibitors: biological functions, recognition of complement components, and potential therapeutic implications. Adv Exp Med Biol 632:221\u2013236","journal-title":"Adv Exp Med Biol"},{"key":"572_CR10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4049\/jimmunol.97.6.822","volume":"97","author":"A Forsgren","year":"1966","unstructured":"Forsgren A, Sjoquist J (1966) \"Protein A\" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol 97:822\u2013827","journal-title":"J Immunol"},{"key":"572_CR11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0968-0004(93)90021-E","volume":"18","author":"CR Goward","year":"1993","unstructured":"Goward CR, Scawen MD, Murphy JP, Atkinson T (1993) Molecular evolution of bacterial cell-surface proteins. Trends Biochem Sci 18:136\u2013140","journal-title":"Trends Biochem Sci"},{"key":"572_CR12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.molimm.2007.10.021","volume":"45","author":"KL Atkins","year":"2008","unstructured":"Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins ATA, Feil EJ, Van den Elsen JMH (2008) S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation. Mol Immunol 45:1600\u20131611","journal-title":"Mol Immunol"},{"key":"572_CR13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.micinf.2004.12.014","volume":"7","author":"SHM Rooijakkers","year":"2005","unstructured":"Rooijakkers SHM, van Wamel WJB, Ruyken M, van Kessel KPM, van Strijp JAG (2005) Anti-opsonic properties of staphylokinase. Microbes Infect 7:476\u2013484","journal-title":"Microbes Infect"},{"key":"572_CR14","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1128\/IAI.69.11.7187-7189.2001","volume":"69","author":"M Collin","year":"2001","unstructured":"Collin M, Olsen A (2001) Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 69:7187\u20137189","journal-title":"Infect Immun"},{"key":"572_CR15","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1093\/emboj\/20.12.3046","volume":"20","author":"M Collin","year":"2001","unstructured":"Collin M, Olsen A (2001) EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 20:3046\u20133055","journal-title":"EMBO J"},{"key":"572_CR16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/IAI.66.2.771-776.1998","volume":"66","author":"S Lukomski","year":"1998","unstructured":"Lukomski S, Burns EH, Wyde PR, Podbielski A, Rurangirwa J, Moore-Poveda DK, Musser JM (1998) Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun 66:771\u2013776","journal-title":"Infect Immun"},{"key":"572_CR17","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1074\/jbc.M704821200","volume":"283","author":"Y Terao","year":"2008","unstructured":"Terao Y, Mori Y, Yamaguchi M, Shimizu Y, Ooe K, Hamada S, Kawabata S (2008) Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J Biol Chem 283:6253\u20136260","journal-title":"J Biol Chem"},{"key":"572_CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1086\/588825","volume":"198","author":"PS Hair","year":"2008","unstructured":"Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM (2008) Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis 198:125\u2013133","journal-title":"J Infect Dis"},{"key":"572_CR19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ni1235","volume":"6","author":"SHM Rooijakkers","year":"2005","unstructured":"Rooijakkers SHM, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Willem JB, Wamel KPM, van Kessel J, van Strijp AG et al (2005) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6:920\u2013927","journal-title":"Nat Immunol"},{"key":"572_CR20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ni.1756","volume":"10","author":"SHM Rooijakkers","year":"2009","unstructured":"Rooijakkers SHM, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJC, van Strijp JAG, Gros P (2009) Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat Immunol 10:721\u2013727","journal-title":"Nat Immunol"},{"key":"572_CR21","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.4049\/jimmunol.0901443","volume":"183","author":"D Ricklin","year":"2009","unstructured":"Ricklin D, Tzekou A, Garcia BL, Hammel M, McWhorter WJ, Sfyroera G, Wu Y, Holers M, Herbert AP, Barlow PN, Geisbrecht BV, Lambris JD (2009) A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family. J Immunol 183:2565\u20132574","journal-title":"J Immunol"},{"key":"572_CR22","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20070818","volume":"204","author":"I Jongerius","year":"2007","unstructured":"Jongerius I, K\u00f6hl J, Pandey MK, Ruyken M, Van Kessel KPM, Van Strijp JAG, Rooijakkers SHM (2007) Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 204:2461\u20132471","journal-title":"J Exp Med"},{"key":"572_CR23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ni1450","volume":"8","author":"M Hammel","year":"2007","unstructured":"Hammel M, Sfyroera G, Ricklin D, Magotti P, Lambris JD, Geisbrecht BV (2007) A structural basis for complement inhibition by Staphylococcus aureus. Nat Immunol 8:430\u2013437","journal-title":"Nat Immunol"},{"key":"572_CR24","doi-asserted-by":"crossref","first-page":"30051","DOI":"10.1074\/jbc.M704247200","volume":"282","author":"M Hammel","year":"2007","unstructured":"Hammel M, Sfyroera G, Pyrpassopoulos S, Ricklin D, Ramyar KX, Pop M, Jin Z, Lambris JD, Geisbrecht BV (2007) Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. J Biol Chem 282:30051\u201330061","journal-title":"J Biol Chem"},{"key":"572_CR25","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.4049\/jimmunol.181.11.7463","volume":"181","author":"D Ricklin","year":"2008","unstructured":"Ricklin D, Ricklin-Lichtsteiner SK, Markiewski MM, Geisbrecht BV, Lambris JD (2008) Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2. J Immunol 181:7463\u20137467","journal-title":"J Immunol"},{"key":"572_CR26","doi-asserted-by":"crossref","first-page":"17579","DOI":"10.1074\/jbc.M800265200","volume":"283","author":"JD Burman","year":"2008","unstructured":"Burman JD, Leung E, Atkins KL, O'Seaghdha MN, Lango L, Bernardo P, Bagby S, Svergun DI, Foster TJ, Isenman DE, van den Elsen JM (2008) Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. J Biol Chem 283:17579\u201317593","journal-title":"J Biol Chem"},{"key":"572_CR27","doi-asserted-by":"crossref","first-page":"e1000250","DOI":"10.1371\/journal.ppat.1000250","volume":"4","author":"K Haupt","year":"2008","unstructured":"Haupt K, Reuter M, van den Elsen J, Burman J, Halbich S, Richter J, Skerka C, Zipfel PF (2008) The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog 4:e1000250","journal-title":"PLoS Pathog"},{"key":"572_CR28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0167-5699(92)90173-5","volume":"13","author":"JH Robinson","year":"1992","unstructured":"Robinson JH, Kehoe MA (1992) Group A streptococcal M proteins: virulence factors and protective antigens. Immunol Today 13:362\u2013367","journal-title":"Immunol Today"},{"key":"572_CR29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/CMR.2.3.285","volume":"2","author":"VA Fischetti","year":"1989","unstructured":"Fischetti VA (1989) Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2:285\u2013314","journal-title":"Clin Microbiol Rev"},{"key":"572_CR30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1126\/science.1154470","volume":"319","author":"C McNamara","year":"2008","unstructured":"McNamara C, Zinkernagel AS, Macheboeuf P, Cunningham MW, Nizet V, Ghosh P (2008) Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science 319:1405\u20131408","journal-title":"Science"},{"key":"572_CR31","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.4049\/jimmunol.160.7.3349","volume":"160","author":"H Kotarsky","year":"1998","unstructured":"Kotarsky H, Hellwage J, Johnsson E, Skerka C, Svensson HG, Lindahl G, Sjobring U, Zipfel PF (1998) Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J Immunol 160:3349\u20133354","journal-title":"J Immunol"},{"key":"572_CR32","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.4049\/jimmunol.157.7.3021","volume":"157","author":"E Johnsson","year":"1996","unstructured":"Johnsson E, Thern A, Dahlback B, Heden LO, Wikstrom M, Lindahl G (1996) A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J Immunol 157:3021\u20133029","journal-title":"J Immunol"},{"key":"572_CR33","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20030543","volume":"198","author":"F Carlsson","year":"2003","unstructured":"Carlsson F, Berggard K, Stalhammar-Carlemalm M, Lindahl G (2003) Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J Exp Med 198:1057\u20131068","journal-title":"J Exp Med"},{"key":"572_CR34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1172\/JCI3065","volume":"102","author":"CD Ashbaugh","year":"1998","unstructured":"Ashbaugh CD, Warren HB, Carey VJ, Wessels MR (1998) Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest 102:550\u2013560","journal-title":"J Clin Invest"},{"key":"572_CR35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.bbrc.2005.11.078","volume":"339","author":"N Tsao","year":"2006","unstructured":"Tsao N, Tsai W, Lin Y, Chuang W, Wang C, Kuo C (2006) Streptococcal pyrogenic exotoxin B cleaves properdin and inhibits complement-mediated opsonophagocytosis. Biochem Biophys Res Commun 339:779\u2013784","journal-title":"Biochem Biophys Res Commun"},{"key":"572_CR36","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.4049\/jimmunol.174.5.2926","volume":"174","author":"R Langley","year":"2005","unstructured":"Langley R, Wines B, Willoughby N, Basu I, Proft T, Fraser JD (2005) The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol 174:2926\u20132933","journal-title":"J Immunol"},{"key":"572_CR37","doi-asserted-by":"crossref","first-page":"8144","DOI":"10.1073\/pnas.82.23.8144","volume":"82","author":"DE Wexler","year":"1985","unstructured":"Wexler DE, Chenoweth DE, Cleary PP (1985) Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci USA 82:8144\u20138148","journal-title":"Proc Natl Acad Sci USA"},{"key":"572_CR38","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1128\/IAI.65.4.1422-1430.1997","volume":"65","author":"LK Husmann","year":"1997","unstructured":"Husmann LK, Yung DL, Hollingshead SK, Scott JR (1997) Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect Immun 65:1422\u20131430","journal-title":"Infect Immun"},{"key":"572_CR39","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1074\/jbc.M412230200","volume":"280","author":"B Postma","year":"2005","unstructured":"Postma B, Kleibeuker W, Poppelier MJJG, Boonstra M, Van Kessel KPM, Van Strijp JAG, De Haas CJC (2005) Residues 10\u201318 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus. J Biol Chem 280:2020\u20132027","journal-title":"J Biol Chem"},{"key":"572_CR40","doi-asserted-by":"crossref","first-page":"12363","DOI":"10.1074\/jbc.M808179200","volume":"284","author":"JH Ippel","year":"2009","unstructured":"Ippel JH, De Haas CJC, Bunschoten A, Van Strijp JAG, Kruijtzer JAW, Liskamp RMJ, Kemmink J (2009) Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus. J Biol Chem 284:12363\u201312372","journal-title":"J Biol Chem"},{"key":"572_CR41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-2567.2001.01249.x","volume":"103","author":"BA Fernie-King","year":"2001","unstructured":"Fernie-King BA, Seilly DJ, Davies A, Lachmann PJ (2001) Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes. Immunology 103:390\u2013398","journal-title":"Immunology"},{"key":"572_CR42","doi-asserted-by":"crossref","first-page":"16561","DOI":"10.1074\/jbc.M301995200","volume":"278","author":"IM Frick","year":"2003","unstructured":"Frick IM, Akesson P, Rasmussen M, Schmidtchen A, Bj\u00f6rck L (2003) SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem 278:16561\u201316566","journal-title":"J Biol Chem"},{"key":"572_CR43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","volume":"30","author":"AP Sjoberg","year":"2009","unstructured":"Sjoberg AP, Trouw LA, Blom AM (2009) Complement activation and inhibition: a delicate balance. Trends Immunol 30:83\u201390","journal-title":"Trends Immunol"},{"key":"572_CR44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1084\/jem.20031636","volume":"199","author":"CJC Haas de","year":"2004","unstructured":"de Haas CJC, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJB, Heezius EC, Poppelier MJ, Van Kessel KP, Van Strijp JAG (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 199:687\u2013695","journal-title":"J Exp Med"},{"key":"572_CR45","doi-asserted-by":"crossref","first-page":"9168","DOI":"10.1073\/pnas.1631716100","volume":"100","author":"IP Gladysheva","year":"2003","unstructured":"Gladysheva IP, Turner RB, Sazonova IY, Liu L, Reed GL (2003) Coevolutionary patterns in plasminogen activation. Proc Natl Acad Sci USA 100:9168\u20139172","journal-title":"Proc Natl Acad Sci USA"},{"key":"572_CR46","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.4049\/jimmunol.173.9.5704","volume":"173","author":"PJ Haas","year":"2004","unstructured":"Haas PJ, de Haas CJC, Kleibeuker W, Poppelier MJ, Van Kessel KPM, Kruijtzer JA, Liskamp RM, Van Strijp JAG (2004) N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. J Immunol 173:5704\u20135711","journal-title":"J Immunol"},{"key":"572_CR47","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood-2007-05-089821","volume":"111","author":"Y Kimura","year":"2008","unstructured":"Kimura Y, Miwa T, Zhou L, Song WC (2008) Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111:732\u2013740","journal-title":"Blood"},{"key":"572_CR48","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1074\/jbc.M508928200","volume":"281","author":"DE Hourcade","year":"2006","unstructured":"Hourcade DE (2006) The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem 281:2128\u20132132","journal-title":"J Biol Chem"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-009-0572-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T12:28:26Z","timestamp":1685363306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-009-0572-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,9]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["572"],"URL":"https:\/\/doi.org\/10.1007\/s00109-009-0572-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,9]]}}}